Next-Generation Prosthetic Heart Valve System with Adaptive and Self-Healing Properties
Legal Citation
Summary of the Inventive Concept
A revolutionary prosthetic heart valve system that integrates advanced materials, sensors, and artificial intelligence to provide real-time monitoring, adaptive shape-memory properties, and self-healing capabilities, enhancing valve performance and patient outcomes.
Background and Problem Solved
The original patent disclosed a prosthetic heart valve with a pericardial sealing member, which, while effective, has limitations in terms of material durability, valve performance, and real-time monitoring. The new inventive concept addresses these limitations by introducing a bio-absorbable stent, self-healing leaflets, and integrated sensors for real-time monitoring, enabling more efficient and effective valve implantation and performance.
Detailed Description of the Inventive Concept
The next-generation prosthetic heart valve system comprises a bio-absorbable stent, a valvular structure with self-healing leaflets, and a perivalvular sealing member with integrated sensors for real-time monitoring of valve performance. The system also features adaptive shape-memory properties, allowing the valve to adjust to changes in blood flow and pressure. Additionally, the valve incorporates artificial intelligence for real-time optimization of valve performance. The system can be fabricated using 3D printing, enabling customized valves with patient-specific geometries.
Novelty and Inventive Step
The new inventive concept's novelty lies in the integration of advanced materials, sensors, and artificial intelligence, which enables real-time monitoring, adaptive shape-memory properties, and self-healing capabilities. The inventive step is the combination of these features, which provides a paradigm shift in prosthetic heart valve design and functionality.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using different types of advanced materials, such as nanofibers or hybrid materials, or incorporating additional features, such as micro-electro-mechanical systems (MEMS) or patient-specific sensors. Variations could also include different valve geometries or configurations, such as a lattice-based frame or a self-organizing valvular structure.
Potential Commercial Applications and Market
The next-generation prosthetic heart valve system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular health and surgical interventions. The target market includes hospitals, clinics, and medical research institutions, with potential applications in valve replacement surgeries, minimally invasive procedures, and personalized medicine.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/2409 |
| A | A61 | A61F2/2415 |
| A | A61 | A61F2/2418 |
| A | A61 | A61L27/3625 |
| A | A61 | A61L27/50 |
| A | A61 | A61L27/56 |
| A | A61 | A61F2/2427 |
| A | A61 | A61F2230/0054 |
| A | A61 | A61F2240/001 |
| A | A61 | A61F2250/0063 |
| A | A61 | A61F2250/0069 |
| A | A61 | A61L2430/20 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Cardiovascular medical devices, specifically prosthetic heart valve systems, involving biomaterials, implantable device design, and advanced medical engineering with expertise in materials science, biomedical engineering, and surgical interventional techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 5-10 years experience in cardiovascular implant design, familiar with materials engineering, surgical implantation techniques, and emerging medical technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's proposed variations represent predictable extensions of existing prosthetic heart valve technologies, leveraging known design principles and emerging materials science techniques. The integration of sensors, adaptive materials, and AI optimization represents incremental improvements using standard engineering approaches. The core functional elements remain consistent with established prosthetic valve design paradigms, suggesting obvious technological progression.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,411 |
|---|---|
| Title | Pericardial sealing member for prosthetic heart valve |
| Assignee(s) | EDWARDS LIFESCIENCES CORPORATION |